关于“新型糖皮质激素软药氯替泼诺乙酯在大鼠和犬体内的药代动力学特征及组织分布”的评论 - Suppr | 超能文献

Comments concerning "Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs".

作者信息

Sloan K B, Perrin J H

出版信息

J Pharm Sci. 1994 Jul;83(7):1066-8. doi: 10.1002/jps.2600830729.

DOI:10.1002/jps.2600830729

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Comments concerning "Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs".关于“新型糖皮质激素软药氯替泼诺乙酯在大鼠和犬体内的药代动力学特征及组织分布”的评论

J Pharm Sci. 1994 Jul;83(7):1066-8. doi: 10.1002/jps.2600830729.

2

Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs.新型糖皮质激素软药氯替泼诺酯在大鼠和犬体内的药代动力学特征及组织分布

J Pharm Sci. 1992 Dec;81(12):1210-5. doi: 10.1002/jps.2600811217.

3

Metabolism, distribution, and transdermal permeation of a soft corticosteroid, loteprednol etabonate.一种软质皮质类固醇——氯替泼诺酯的代谢、分布及经皮渗透

Pharm Res. 1992 Oct;9(10):1275-8. doi: 10.1023/a:1015849132396.

4

Soft drugs. 19. Pharmacokinetics, metabolism and excretion of a novel soft corticosteroid, loteprednol etabonate, in rats.软性药物。19. 新型软性皮质类固醇药物氯替泼诺乙酯在大鼠体内的药代动力学、代谢及排泄情况

Pharm Res. 1995 Jun;12(6):875-9. doi: 10.1023/a:1016265105139.

5

Soft drugs--10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: loteprednol etabonate.软性毒品——10. 新型糖皮质激素氯替泼诺乙酯的皮肤变白活性和受体结合亲和力。

J Steroid Biochem Mol Biol. 1991 Feb;38(2):149-54. doi: 10.1016/0960-0760(91)90120-t.

6

Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes.软质类固醇药物氯替泼诺乙酯在兔眼中的眼部吸收与分布。

Curr Eye Res. 1991 Oct;10(10):933-7. doi: 10.3109/02713689109020329.

7

Soft drugs. 18. Oral and rectal delivery of loteprednol etabonate, a novel soft corticosteroid, in rats--for safer treatment of gastrointestinal inflammation.软药。18. 新型软皮质类固醇洛替泼诺酯在大鼠体内的口服和直肠给药——用于更安全地治疗胃肠道炎症

Pharm Res. 1995 Jun;12(6):869-74. doi: 10.1023/a:1016213121069.

8

Permeability of a soft steroid, loteprednol etabonate, through an excised rabbit cornea.一种软性类固醇药物——氯替泼诺妥布酯透过离体兔角膜的通透性。

J Ocul Pharmacol Ther. 1996 Summer;12(2):159-67. doi: 10.1089/jop.1996.12.159.

9

Systemic bioavailability of fluticasone proprionate.丙酸氟替卡松的全身生物利用度。

Br J Clin Pharmacol. 2001 Oct;52(4):457-60. doi: 10.1046/j.0306-5251.2001.01456.x-i3.

10

Failure to detect systemic levels, and effects of loteprednol etabonate and its metabolite, PJ-91, following chronic ocular administration.长期眼部给药后未能检测到氯替泼诺及其代谢产物PJ - 91的全身水平及效应。

J Ocul Pharmacol Ther. 1998 Apr;14(2):153-8. doi: 10.1089/jop.1998.14.153.

引用本文的文献

1

Soft drugs based on hydrocortisone: the inactive metabolite approach and its application to steroidal antiinflammatory agents.

Pharm Res. 1999 Jun;16(6):961-7. doi: 10.1023/a:1018907026460.